NTCOC
IONS icon

Northern Trust Company of Connecticut’s Ionis Pharmaceuticals IONS Stock Holding History

Northern Trust Company of Connecticut’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$111K Buy
2,780
+1,890
+212% +$67.3K ﹤0.01% 1865
2013
Q3 		$33K Buy
+890
New +$26.6K ﹤0.01% 1942

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Company of Connecticut's IONS Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its Ionis Pharmaceuticals (IONS) stake by 212% in Q4 2013, buying an estimated $67.3K and bringing the position to 2,780 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

Northern Trust Company of Connecticut first reported a position in IONS in Q3 2013 and has held it in 2 quarters since. 213 funds tracked by Wall St. Rank hold IONS as of Q4 2013.

  • Northern Trust Company of Connecticut held 2,780 shares of Ionis Pharmaceuticals worth $111K as of Q4 2013.
  • Northern Trust Company of Connecticut bought 1,890 Ionis Pharmaceuticals shares in Q4 2013, an estimated $67.3K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1865 holding.
  • Northern Trust Company of Connecticut first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 2 quarters since.
  • 213 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.